Loading live market data…

Cue Biopharma, Inc.

NASDAQ:CUE

$31.28 USD

$0.36 (1.16%)

Volume
163.14K
Average Volume
583.16K
Market Capitalization
$82.2M
P/E Ratio
-5.67
Dividend Yield
0.00%
Price Target
$4.00
Year High
$45.50
Year Low
$4.98
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.57

CUE Estimated and Actual Revenue by Quarter

CUE Estimated and Actual EPS by Quarter

CUE Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 1 -1.92M -1.92M -1.92M -1.97M -1.97M -1.97M
2026-09-30 1 -2.02M -2.02M -2.02M -2.07M -2.07M -2.07M
2026-06-30 1 -2.89M -2.89M -2.89M -2.96M -2.96M -2.96M
2026-03-31 1 -2.41M -2.41M -2.41M -2.47M -2.47M -2.47M
2025-12-31 1 -962.13K -962.13K -962.13K -987.47K -987.47K -987.47K
2025-09-30 2 -2.2M -2.2M -2.2M -2.26M -2.26M -2.26M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 1 -9.47M -9.47M -9.47M 7.74M 7.74M 7.74M
2026-09-30 1 -9.18M -9.18M -9.18M 8.13M 8.13M 8.13M
2026-06-30 1 -8.12M -8.12M -8.12M 11.61M 11.61M 11.61M
2026-03-31 1 -15.86M -15.86M -15.86M 9.67M 9.67M 9.67M
2025-12-31 1 -12.98M -12.98M -12.98M 3.87M 3.87M 3.87M
2025-09-30 2 -13.46M -13.46M -13.46M 8.86M 8.86M 8.86M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 1 2M 2M 2M 1 -1.97 -1.97 -1.97
2026-09-30 1 2.1M 2.1M 2.1M 1 -1.91 -1.91 -1.91
2026-06-30 1 3M 3M 3M 1 -1.69 -1.69 -1.69
2026-03-31 1 2.5M 2.5M 2.5M 1 -3.3 -3.3 -3.3
2025-12-31 1 1M 1M 1M 1 -2.7 -2.7 -2.7
2025-09-30 2 2.29M 2.29M 2.29M 1 -2.8 -2.8 -2.8